| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/25/2010 | WO2009140429A3 Micellic assemblies |
| 02/25/2010 | WO2009140198A3 Pathogen detection and screening |
| 02/25/2010 | WO2009137763A3 Methods and compositions for the display of polypeptides on the pili of gram-positive bacteria |
| 02/25/2010 | WO2009134443A3 Rna-induced translational silencing and cellular apoptosis |
| 02/25/2010 | WO2009129250A3 Meal-time insulin analogues of enhanced stability |
| 02/25/2010 | WO2009126927A3 Methods of generating insulin-producing cells |
| 02/25/2010 | WO2009120877A9 Microrna-based diagnostic testing and therapies for inflammatory bowel disease and related diseases |
| 02/25/2010 | WO2009120806A3 Expression of oxidoreductases to increase volumetric productivity |
| 02/25/2010 | WO2009117656A9 Capsid-incorporated antigen for novel adenovirus vaccine |
| 02/25/2010 | WO2009114702A3 Recombinant production of authentic human proteins using human cell expression systems |
| 02/25/2010 | WO2009113795A3 Vector and method for expressing avian influenza virus neuraminidase n1 in e. coli, method of using the vector, and neuraminidase inhibitors |
| 02/25/2010 | WO2009104092A3 Escherichia coli immunogens with improved solubility |
| 02/25/2010 | WO2009102569A4 Cell lines and methods for making and using them |
| 02/25/2010 | WO2009020346A9 A gastric carcinoma gene znf312b, a protein translated from the gene, and a diagnostic kit and a screening method for anticancer agents using the same |
| 02/25/2010 | WO2009013621A3 Antibodies and sirna against growth hormone, prolactin and proliferin for use in the treatment of tumors and endometriosis |
| 02/25/2010 | WO2005081873A9 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 02/25/2010 | US20100050303 Antimicrobial Agents from Microbial Genomes |
| 02/25/2010 | US20100050301 System for capturing and modifying large pieces of genomic dna and constructing vascular plants with synthetic chloroplast genomes |
| 02/25/2010 | US20100050298 Mutants of pha synthase from pseudomonas sp. 6-19 and method for preparing lactate homopolymer or copolymer using the same |
| 02/25/2010 | US20100050297 Plants having modified growth characteristics and method for making the same |
| 02/25/2010 | US20100050296 Preparation of organisms with faster growth and/or higher yield |
| 02/25/2010 | US20100050295 Methods and means for removal of a selected dna sequence |
| 02/25/2010 | US20100050293 Improvement of nitrogen responsiveness in plants through the expression of pathways for the formation and catabolism of novel n-rich compounds |
| 02/25/2010 | US20100050292 Galactosyltransferase |
| 02/25/2010 | US20100050290 Soybean variety d5462579 |
| 02/25/2010 | US20100050288 Soybean variety d5864369 |
| 02/25/2010 | US20100050287 Soybean variety d5567891 |
| 02/25/2010 | US20100050285 Soybean variety d5689411 |
| 02/25/2010 | US20100050284 Soybean variety d5232543 |
| 02/25/2010 | US20100050283 Soybean variety d5236984 |
| 02/25/2010 | US20100050281 Identification of Genes and Their Products Which Promote Hybrid Vigour or Hybrid Debility and Uses Thereof |
| 02/25/2010 | US20100050280 Recombinant constructs and transgenic fluorescent ornamental fish therefrom |
| 02/25/2010 | US20100050279 High efficiency flp site-specific recombination in mammalian cells using an optimized flp gene |
| 02/25/2010 | US20100050277 Knockout animal exhibiting anxiety-like behavior |
| 02/25/2010 | US20100050276 Transgenic non-human animal models of apoptosis-mediated conditions |
| 02/25/2010 | US20100049491 Method and System for Optimizing Minigenes and Peptides Encoded Thereby |
| 02/25/2010 | US20100049446 Gene classifying method, gene classifying program, and gene classifying device |
| 02/25/2010 | US20100048878 Human gene |
| 02/25/2010 | US20100048876 Chromatography ligand comprising domain c from staphylococcus aureus protein a for antibody isolation |
| 02/25/2010 | US20100048867 Device and process for purifying nucleic acids |
| 02/25/2010 | US20100048864 Expression vector comprising nucleotoide sequences coding signal sequences which direct proteins to periplasmic compartment; improving exogenous expression of heterologous polypeptides |
| 02/25/2010 | US20100048683 Modified vaccinia virus ankara for the vaccination of neonates |
| 02/25/2010 | US20100048682 Inhibiting dna polymerase beta to enhance efficacy of anticancer agents |
| 02/25/2010 | US20100048679 Polynucleotide therapy |
| 02/25/2010 | US20100048678 Nucleic acids and polypeptides that are useful in controlling neuronal regeneration |
| 02/25/2010 | US20100048677 Regulation of Integrin Surface Expression |
| 02/25/2010 | US20100048675 miRNA TRIPLEX FORMATIONS FOR THE DOWNREGULATION OF VIRAL REPLICATION |
| 02/25/2010 | US20100048672 Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications |
| 02/25/2010 | US20100048671 Inhibition of the 44 kilodalton isoform of pim-1 kinase restores apoptosis induced by chemotherapeutic drugs in cancer cells |
| 02/25/2010 | US20100048670 Stable and Long-Lasting siRNA Expression Vectors and the Applications Thereof |
| 02/25/2010 | US20100048487 Novel cell penetrating peptide |
| 02/25/2010 | US20100048486 Use of Soluble Fgl2 As An Immunosuppressant |
| 02/25/2010 | US20100048485 Substrates of n-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrate |
| 02/25/2010 | US20100048480 Production of anti-microbial peptides |
| 02/25/2010 | US20100048472 Albumin Fusion Proteins |
| 02/25/2010 | US20100048470 Immunotoxins for the treatment of diseases related to cmv infection |
| 02/25/2010 | US20100048469 Antimicrobial peptides |
| 02/25/2010 | US20100048466 Compositions, Reagents and Kits for and Methods of Diagnosing, Monitoring and Treating Hormonal Imbalance |
| 02/25/2010 | US20100048458 Tribonectins |
| 02/25/2010 | US20100048446 TS23 Alpha-Amylase Variants With Altered Properties |
| 02/25/2010 | US20100048426 Enhanced Expression from the Pm Promoter |
| 02/25/2010 | US20100048417 NOVEL BACILLUS 029cel CELLULASE |
| 02/25/2010 | US20100048413 Ob fold domains |
| 02/25/2010 | US20100047909 Nucleic acid compounds for inhibiting vegf family gene expression and uses thereof |
| 02/25/2010 | US20100047904 Materials, methods and systems for purification and/or separation |
| 02/25/2010 | US20100047903 Methods of processing compositions containing microparticles |
| 02/25/2010 | US20100047900 culturing the transformed host cell (coryneform bacterium) in a medium supplemented with L-Lysine under conditions wherein a target gene is expressed |
| 02/25/2010 | US20100047897 Process for producing modified reconstituted sendai viral envelope specific for drug and/or gene delivery to liver cells |
| 02/25/2010 | US20100047896 Nucleic acid construct containing full length genome of human hepatitis C virus, recombinant full length virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus particle |
| 02/25/2010 | US20100047895 Methods for purification of bacterial cells and cell components |
| 02/25/2010 | US20100047894 Use of Matrix Metalloproteinases, Mutated and Not Mutated, for the Preparation of Pharmaceutical Compositions, and Mutated Metalloproteinases with Increased Stability |
| 02/25/2010 | US20100047893 Recombinant arginine methyltransferase encoded by nucleic acid sequences of Trypanosoma brucei |
| 02/25/2010 | US20100047890 Methods and compositions for generating sporulation deficient bacteria |
| 02/25/2010 | US20100047880 Production of n-acylated sulphur-containing amino acids with microorganisms having enhanced n-acyltransferase enzymatic activity |
| 02/25/2010 | US20100047877 polynucleotides encoding the phospholipases; using these enzymes in industrial processes and methods of diagnosing fungal infections; Aspergillus niger; recombinant host cells wherein the expression of a phospholipase is significantly increased or wherein the activity of the phospholipase is increased |
| 02/25/2010 | US20100047871 Fusion proteins of hiv regulatory/accessory proteins |
| 02/25/2010 | US20100047868 Tumour Suppressor Protein |
| 02/25/2010 | US20100047867 Il-1 zeta, il-1 zeta splice variants and xrec2 dnas and polypeptides |
| 02/25/2010 | US20100047866 Heat-Stable Carbonic Anhydrases and Their Use |
| 02/25/2010 | US20100047865 Vector for expressing nc protein of hiv and method for producing nc protein using the same |
| 02/25/2010 | US20100047863 Group of novel enantiosleective microbial nitrile hydratases with broad substrate specificity |
| 02/25/2010 | US20100047862 Novel DNA Polymerase |
| 02/25/2010 | US20100047846 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 02/25/2010 | US20100047818 Diagnosis of carcinomas |
| 02/25/2010 | US20100047809 Pca3, pca3 genes, and methods of use |
| 02/25/2010 | US20100047805 Methods and compositions for targeted single-stranded cleavage and targeted integration |
| 02/25/2010 | US20100047776 Cell-based screening assays for compounds that regulate the expresion of a tumor marker dj-1 |
| 02/25/2010 | US20100047769 having controlling effects on growth and differentiation of undifferentiated cells; can affect stem cells to trigger the growth arrest signal; inhibits a SELF promoter activity |
| 02/25/2010 | US20100047763 Plasmid Expression Vectors for Expression of Recombinant Rotavirus and Astrovirus Proteins or Epitopes |
| 02/25/2010 | US20100047392 Enzymes Having Alpha Amylase Activity and Methods of Making and Using Them |
| 02/25/2010 | US20100047388 Lipolytic Enzyme Variants |
| 02/25/2010 | US20100047387 Transformed saccharomyces yeast strains having reduced ethanol production by fermentation |
| 02/25/2010 | US20100047384 Methods of producing transformation competent bacteria |
| 02/25/2010 | US20100047368 Compositions and methods for the treatment or prevention of chemoresistant neoplasia |
| 02/25/2010 | US20100047336 Inhibition of brain enzymes involved in cerebral amyloid angiopathy and macular degeneration |
| 02/25/2010 | US20100047280 Flavivirus ns1 subunit vaccine |
| 02/25/2010 | US20100047277 Virosomes, methods of preparation, and immunogenic compositions |
| 02/25/2010 | US20100047276 Recombinant Vectors Based On the Modified Vaccinia Ankara Virus (MVA) as Preventive and Therapeutic Vaccines Against Aids |
| 02/25/2010 | US20100047268 Fusion proteins of hiv regulatory/accessory proteins |
| 02/25/2010 | US20100047267 Staphylococcus aureus proteins and nucleic acids |